Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
Identification of Bax-Interacting Proteins in Normal Oligodendrocyte Progenitors during Glutamate Excitotoxicity and Perinatal Hypoxia-Ischemia.
[The effect of genetic factors on the phenotypic expression of multiple sclerosis.]
Restless legs syndrome associated with major diseases: A systematic review and new concept.
Study of type a and B behavior patterns in patients with multiple sclerosis in an Iranian population.
Origins of oligodendrocytes in the cerebellum, whose development is controlled by the transcription factor, Sox9.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Effects of long-term whole-body vibration training on mobility in patients with multiple sclerosis: A meta-analysis of randomized controlled trials.
Kif13b Regulates PNS and CNS Myelination through the Dlg1 Scaffold.
The effect of executive function on stress, depression, anxiety, and quality of life in multiple sclerosis.
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
Systematic Review and meta-analysis of the Efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in Animal Models of Stroke.
PERK-opathies: an endoplasmic reticulum stress mechanism underlying neurodegeneration.
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.
The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.
Mode of action and clinical studies with fumarates in multiple sclerosis.
Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy.
Health-related quality of life among latinos with multiple sclerosis.
Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response.
Opening locked doors: Integrating a palliative care approach into the management of patients with severe multiple sclerosis.
[Th17/Treg unbalance is involved in the pathogenesis of experimental autoimmune encephalomyelitis].
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.
Physical Activity in Multiple Sclerosis: A Comparative Study of Vitamin D, Brain-Derived Neurotrophic Factor and Regulatory T Cell Populations.
Use of a physiological profile to document motor impairment in ageing and in clinical groups.
Pages
« first
‹ previous
…
454
455
456
457
458
459
460
461
462
…
next ›
last »